Brief: Vicore Pharma Q2 Operating Loss At SEK 64.9 Mln
25/08/2022 07:22
Aug 25 (Reuters) - Vicore Pharma Holding AB VICOR.ST :
* Q2 NET SALES AMOUNTED TO 0.0 MSEK (0.0)
* Q2 OPERATING LOSS WAS -64.9 MSEK (-68.4)
* Q2 LOSS FOR PERIOD AMOUNTED TO -65.9 MSEK (-70.4)
Source text for Eikon: ID:nWkrbtQ22H
Further company coverage: VICOR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Vicore Pharma Holding AB
See all newsBrief: Vicore Pharma Holding Q3 Net Revenues Amounted To Sek 0.6 Mln
Brief: Vicore Pharma Holding AB Phase 2B Aspire Trial Of Buloxibutid In Ipf Passes Pre-Planned Futility Analysis, On Track For Mid-2027 Topline Results
Brief: Vicore Pharma Q2 Operating Loss At SEK 150.1 Million
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:53 PM
Brief: Vicore Pharma Shares Start Trading In US On July 2